Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway
- Resource Type
- Journal
- Source
ONCOTARGET ; JAN 9 2018, 9 3, p3267-p3277, 11p.- Subject
- Language
- English
- ISSN
- 19492553